Gastroenterologist, special interest in IBD, IUS, clinical research, Advanced clinical and research fellowship in IBD, University of Western Ontario, Canada.
Our recent study on ASUC.
Colectomy at
Discharge-8%
1 yr-13.5%
3yr -16.1%
5yr- 17.4%
Steroid responders and non-responders have similar outcomes.
Day-3 Oxford criteria remain relevant in post biologic era
@vipuljairath@virgisolitano
https://t.co/iO5RVISIT6
Development and external validation of an endoscopic and histologic pouchitis assessment tool: the Atlantic Pouchitis Index
Congrats to @RocioSedanoMD for leading this over the last 5 years and to all collaborators for their guidance and input. https://t.co/wPdV5OyNro
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease. Much needed effort to standardize the approach to steroids in trials lead by @ChrisMa_YYC with global contributions! https://t.co/2uAR3EBAxp
Department of Medicine Residents Research Day. This year we had 95 abstracts from our trainees sharing their research from basic science, clinical research, QI and education research. Thanks to all of our trainees and faculty who made this a success @SchulichMedDent@WesternU
Excited to share that I’ve completed the IBUS training in intestinal ultrasound for IBD. Grateful to learn this new skill #IBUS
Thanks to Dr.Siwar Albashir, Dr.Prowse at McMasters and @GordonMoranIBD@drgauraang@vipuljairath for encouragement and support @BowelUltrasound
📢 Join us on Tuesday, May 20th at 1:00 PM CET for another exclusive IBUS SciCom Webinar on "Standardized IUS Scoring in IBD" with Dr. Gabriele Dragoni, Dr. Chris Ma and Dr. Christoph Teichert
👉 Visit the IBUS website for more details and to register: https://t.co/7I0YEJtfbo
💥Our latest on how AI is revolutionizing IBD CTs!💥 AI is boosting patient recruitment, trial efficiency, personalized ttm, endpoint assessment & tackling key ethical & reg challenges👇@vipuljairath@virgisolitano @chrisma_yyc @olga_nardone@IBDologist https://t.co/F5r7Bk8vaP
How often during a colonoscopy in a patient w #CD could we have missed lesions that would have led to a change in therapy?
I’ve wondered about this many times @virgisolitano addresses it in her 📄
🔍 22.3% had lesions proximal to the TI
🔍 24.5% SB skip lesions in the ileum
🔍 10.4% had strictures
@vipuljairath@IBDJournals
https://t.co/XIJDT3QwlH